Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Development of Autistic Brains Versus Healthy Brains

October 21, 2011 12:04 pm | News | Comments

Researchers at UCLA have found a possible explanation for why autistic children act and think differently than their peers.

TOPICS:

Lisdexamfetamine Dimesylate Proves Effective for ADHD

October 21, 2011 12:00 pm | News | Comments

Shire announced positive results of a European Phase 3 study of once-daily lisdexamfetamine dimesylate in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.

TOPICS:

Target Identified To Decrease Triglycerides, Increase Cholesterol

October 21, 2011 11:32 am | News | Comments

Researchers announce findings that show the inhibition of both microRNA-33a and microRNA-33b with chemically modified anti-miR oligonucleotides suppress triglyceride levels and cause an increase in high density lipoprotein cholesterol.

TOPICS:
Advertisement

Barcoded Tubes

October 21, 2011 8:05 am | Product Releases | Comments

Thermo Fisher Scientific Inc. introduced its Matrix Amber 2D barcoded tubes, expanding its sizeable sample storage product portfolio to offer protection of light-sensitive samples.

TOPICS:

Supercritical Fluid Extractor

October 21, 2011 8:03 am | Product Releases | Comments

Supercritical Fluid Technologies, Inc.’s SFT-250 supercritical fluid extractor is designed to perform a variety of extractions in supercritical fluid and is engineered to meet the day-to-day rigors of the research lab.

TOPICS:

Researchers Use T2MR to Detect Candida

October 21, 2011 7:53 am | News | Comments

Two independent groups from Massachusetts General Hospital and University of Houston College of Pharmacy used the T2MR platform to analyze whole blood specimens from patients with 5 different types of Candida spp. infections.

TOPICS:

Sagent Bupivacaine Approved by FDA

October 21, 2011 7:48 am | News | Comments

Sagent Pharmaceuticals, Inc. announced U.S. FDA approval of bupivacaine hydrochloride injection, USP, a local or regional anesthetic. Sagent's bupivacaine will be available in six single-dose and two multi-dose latex-free vials.

TOPICS:

Merck Reports Positive Boceprevir Results

October 21, 2011 7:44 am | News | Comments

Merck announced results from a Phase 2b study evaluating the investigational use of Victrelis in combination with peginterferon alfa and ribavirin for the treatment of chronic HCV genotype 1 infection in adult patients coinfected with HIV-1.

TOPICS:
Advertisement

FDA Approves Watson Patch

October 21, 2011 7:22 am | News | Comments

Drugmaker Watson Pharmaceuticals Inc. said that the Food and Drug Administration has approved its testosterone patch Androderm in a smaller size and lower dose.

TOPICS:

Hedge Fund Under SEC Microscope Over Cougar Deal

October 21, 2011 7:20 am | News | Comments

Hedge fund SAC Capital Advisors LP is being investigated by federal regulators for using inside information to profit from a health care takeover in 2009, the Wall Street Journal reported.

TOPICS:

Amgen Likely to Highlight Sales Prospects

October 21, 2011 7:16 am | News | Comments

Amgen Inc., the world's largest biotech company by revenue, likely will focus on sales prospects for its top drugs and progress on its experimental drugs when it reports third-quarter results.

TOPICS:

EU Opens Antitrust Probe into Novartis, J & J

October 21, 2011 7:12 am | News | Comments

The European Union is investigating whether drug companies Novartis and Johnson & Johnson colluded to keep a generic painkiller out of the Dutch market, the bloc's antitrust watchdog said.

TOPICS:

Early HIV Treatment Increases Tuberculosis Patients Survival

October 20, 2011 12:38 pm | News | Comments

Starting HIV therapy in patients with both HIV and tuberculosis within two weeks of TB treatment increases survival by 33%.

TOPICS:

Byetta Approved for Insulin Glargine Use

October 20, 2011 12:35 pm | News | Comments

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration has approved a new use for Byetta (exenatide) injection.

TOPICS:

Bristol-Myers Squibb Senior VP Departs

October 20, 2011 12:32 pm | News | Comments

Drugmaker Bristol-Myers Squibb Co. said that its commercial operations senior vice president, Anthony C. Hooper, has left the company.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading